Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,684,022
+$150,787 QoQ
Shares Held
12,935
+0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#875
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AIMZ Investment Advisors, LLC holds $37,637,360 across 11 Drug Manufacturers - General names. AMGN ranks #3 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
61,319 | $7,747,042 | |
| 2 | AZN |
Astrazeneca PLC
|
27,221 | $5,161,646 | |
| 3 | AMGN |
Amgen Inc
This page
|
12,935 | $4,684,022 | |
| 4 | ABBV |
AbbVie Inc.
|
15,376 | $3,869,216 | |
| 5 | JNJ |
Johnson & Johnson
|
13,954 | $3,543,897 | |
| 6 | MRK |
Merck & Co., Inc.
|
25,475 | $3,273,537 | |
| 7 | GSK |
GSK plc
|
59,214 | $3,103,997 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,522 | $3,026,317 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,684,022 | 12,935 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,533,235 | 12,884 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,236,700 | 12,944 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,677,630 | 13,032 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,663,235 | 13,120 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,118,379 | 13,219 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,444,878 | 13,217 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,306,336 | 13,365 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,230,260 | 13,539 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,892,909 | 13,692 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $4,065,402 | 14,115 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $3,835,473 | 14,271 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,190,427 | 14,370 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,473,464 | 14,368 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $3,792,784 | 14,441 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,350,345 | 14,864 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,622,250 | 14,888 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $3,616,659 | 14,956 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,454,189 | 15,354 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,179,755 | 14,953 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,651,131 | 14,979 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,737,375 | 15,021 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $3,489,955 | 15,179 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,857,640 | 15,178 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,623,281 | 15,362 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $3,129,137 | 15,435 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||